Remove 2022 Remove Healthcare Provider Remove Safety Remove Side effects
article thumbnail

Navigating the Regulatory Environment of Pharmaceutical Marketing: Balancing Patient Safety and Industry Innovation

Pharma Marketing Network

Pharmaceutical marketing is a critical aspect of the industry, as it helps in spreading awareness about the benefits and potential side effects of different drugs. In recent years, digital marketing has become an increasingly important tool for pharmaceutical companies to reach patients and healthcare providers.

Safety 52
article thumbnail

Almirall/Lilly lebrikizumab offers potential long-term management of atopic dermatitis

pharmaphorum

Findings presented at EADVC 2022. The week 16 data of lebrikizumab […] points towards a drug with robust efficacy with hardly any safety trade-offs. Minor side effects to long-term maintenance balance. Any clinical study seeks to achieve maximum results efficacy with minimal occurrence of side effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA backs pharmacist prescribing of Paxlovid for COVID

pharmaphorum

Specifically, the pharmacist will need to see records that are less than 12 months old and include blood test results that can be used to check for kidney or liver problems, or be able to consult with the patient’s healthcare provider. — President Biden (@POTUS) July 7, 2022.

FDA 109
article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.

Safety 102
article thumbnail

Healthcare Watch October 2023

PM360

“They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP). And while they’re excited about the drugs’ results and limited side effects now, many also noted concerns about the lack of safety data and long-term risks.

article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

Then, the MRL team and the influencer must align on where there is flexibility within messaging while still abiding to brand safety guidelines, as you don’t want to lose the authenticity that the influencer brings. For example, everyone must be steeped in both FDA and FTC guidelines. Rishi Kadiwar.